|

The Effect of IBD Flares on Serum PSA

RECRUITINGSponsored by Northwestern University
Actively Recruiting
SponsorNorthwestern University
Started2019-08-01
Est. completion2025-10-01
Eligibility
Age40 Years – 69 Years
SexMALE
Healthy vol.Accepted
Locations1 site
View on ClinicalTrials.gov →

NCT03558048

Summary

This study will measure Prostate Specific Antigen (PSA) values in men with Inflammatory Bowel Disease (IBD) before, during, and following a flare. In addition, the effect of any PSA increase will be analyzed and correlated to the location of disease (rectal vs. other). Study findings may help men with IBD by identifying pitfalls in prostate cancer screening for this population and help to stratify and understand the effect IBD has on the prostatic milieu. By optimizing how men with IBD are screened for prostate cancer, future unnecessary healthcare encounters and expenditures may be reduced for this patient group.

Eligibility

Age: 40 Years – 69 YearsSex: MALEHealthy volunteers accepted
Inclusion Criteria:

* Men, ages 40-69 years old
* Confirmed diagnosis of IBD presenting to the Northwestern Memorial Hospital Gastroenterology Clinic

Exclusion Criteria:

* History of prostate cancer or prior prostate procedures (biopsies or transurethral resection)

Conditions3

CancerInflammatory Bowel DiseasesProstate Cancer

Locations1 site

Northwestern Medicine
Chicago, Illinois, 60611
Jazmine Stockdale312-695-8146

Browse More Trials

Cancer trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.